PRODUCTS
The Ramporsil platform technology is applicable to a wide range of drug delivery needs. We focus on the parenteral and local administration of drug products. Our technology is also for the controlled release of small molecules and biopharmaceuticals. It is suitable for delivering all types of molecules, compounds, peptides, RNA, proteins, antibodies, carbohydrates, and viruses, which can be encapsulated and delivered. Multiple administration routes (subcutaneous, intramuscular) can be used, and various periods of release (one day to more than one week) can be achieved. RNT’s cost-effective, scaled manufacturing provides unparalleled flexibility to address numerous diseases and large patient populations.
Ramporsil technology can also be used in other areas, such as fluorescence tagging, diagnostics, and imaging.
Some of the competitive advantages of Ramporsil technology over alternative technologies are as follows:
SAFETY:
Fully biocompatible and non-toxic. It improves drug bioavailability, pharmacokinetics, and therapeutic efficacy. It influences the drug release rate and the drug's systemic distribution/targeting. It influences the biocompatibility of the drug delivery system to ensure efficient and safe drug delivery.
CONTROLLED RELEASE:
Silicon dissolution can be adjusted over many days. Porous silicon is fully biodegradable by dissolution in body fluids.
VERSATILITY:
Suitable for highly water-soluble and poorly water-soluble compounds. Suitable for small molecules, biomolecules, and viruses. Administration in various dosage forms (microparticles, gels, injections). Multiple administration routes (subcutaneous, intramuscular)